| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.003 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.003 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.006 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.006 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.007 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |